Close

Add to pipeline

Save Close
You are viewing a limited version of this profile. To access i3's full capabilities.
Arcadia Biosciences
Save
Company logo (jpg or png)
Parent company
Edit alternate names

Short description

Developer of agricultural technologies such as low water and nitrogen consuming plants, salt tolerant plants, and extended shelf-life produce

Founded in 2002
Founded in

Company type Public Public (RKDA)
Company type

Industry Group agriculture & food

Sector crop inputs

TRL Range 7-8
TRL 1 Basic research
TRL 2 Technology formulation
TRL 3 Applied research
TRL 4 Small scale prototype
TRL 5 Large scale prototype
TRL 6 Prototype system
TRL 7 Demonstration system
TRL 8 First of a kind commercial system
TRL 9 Full commercial application
TRL Range

Ticker

Headquarters Davis, CA Davis, United States
Address
City
State
Zip
Country

Parent Companies

Website

Updated by Jonathan Koch at on 02/02/2018

Edited by Cleantech Group on 03/17/2023

Traction
  • 1 M&A items
tags
Similar companies
Customers
Save
Add Customer
Date Company
02/16/2012

U.S. Sugar Corporation U.S. Sugar Corporation

Arcadia and the U.S. Sugar Corporation will work together to develop Nitrogen Use Efficient (NUE) and Water Efficient (WE) sugarcane.

Confirmed by U.S. Sugar Corporation
Delete
Partnerships
Save
Add Partnership
Date Partner Type
11/21/2013
DuPont Pioneer DuPont Pioneer
The two companies plans to collaborate on sorghum technology development.
View source    
Confirmed by DuPont Pioneer
Technology Partner
Delete
Investment Rounds
Save

IPO INFORMATION

Date

05/01/2015

IPO status

Listed

IPO Type

IPO

Amount

$68.2M

Initial shares

8528306

Ticker symbol

RKDA

Exchange listed

NASDAQ

Prospectus URL

Prospectus

Source URL

Source

Description

Arcadia has settled on an initial share price of $8. Credit Suisse Securities and J.P. Morgan Securities are acting as joint lead book-running managers, and Piper Jaffray & Co. is acting as an additional book-running manager, for the offering.

Cancel Save
Add Investment
Date Investors Type Amount
03/03/2023 (0)
Post-money valuation of
Arcadia Biosciences (NASDAQ:RKDA) entered into securities purchase agreements for the purchase and sale of shares and preferred investment options. Gross proceeds are expected to be $6M; net proceeds to be used for supporting Project Greenfield, its 3-year plan to unlock the company's potential and create a path to profitability. Offer is expected to close on or about March 6, 2023.
 Follow-on Public Offering $6,000,000
Delete
Click to add IPO information
Products
Save
Add Product
Product image Name Product status Revenue model Cost metrics

GLA Safflower Oil

Arcadia is developing safflower seeds containing oil with as much as 40 percent GLA (a fatty acid), making its production more efficient.

 Pilot/Early Revenue Products - Retail
$/kW (current)
$/kW (projected)
$/kWh (current)
$/kWh (projected)
Delete
You are viewing a limited version of this profile. To access i3's full capabilities.
Back to top

Preload svg text font